Next Article in Journal

Real-World Study on Vedolizumab Serum Concentration, Efficacy, and Safety after the Transition from Intravenous to Subcutaneous Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Experience

Next Article in Special Issue

The STAT3-Regulated Autophagy Pathway in Glioblastoma

Previous Article in Journal

Renin–Angiotensin System Antagonism Protects the Diabetic Heart from Ischemia/Reperfusion Injury in Variable Hyperglycemia Duration Settings by a Glucose Transporter Type 4-Mediated Pathway

Previous Article in Special Issue

Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessReview

Article Versions Notes

Pharmaceuticals 2023, 16(2), 240; https://doi.org/10.3390/ph16020240

Action	Date	Notes	Link
article pdf uploaded.	5 February 2023 09:03 CET	Version of Record	https://www.mdpi.com/1424-8247/16/2/240/pdf-vor
article xml file uploaded	21 February 2023 11:10 CET	Original file	-
article xml uploaded.	21 February 2023 11:10 CET	Update	https://www.mdpi.com/1424-8247/16/2/240/xml
article pdf uploaded.	21 February 2023 11:10 CET	Updated version of record	https://www.mdpi.com/1424-8247/16/2/240/pdf
article html file updated	21 February 2023 11:11 CET	Original file	https://www.mdpi.com/1424-8247/16/2/240/html

Back to TopTop